therapy can be called cancer treatment' crown due to its low cost, short course of treatment (30 minutes to 60 minutes each time, and only one to two treatments at the fastest), wide indications, and low side effects. "The pearl of life'
Fasting blood glucose, OGTT... Before doing these tests, ask about the use of the following drugs!
Time of Update: 2021-11-15
Non-dihydropyridine CCBs, such as sustained-release verapamil and diltiazem, basically do not affect plasma renin activity and aldosterone concentration, and can be used for those who need to detect ARR but cannot stop antihypertensive drugs .
Can targeted drugs be tested blindly?
Time of Update: 2021-11-14
In the LUX-LUNG clinical trial, the second-generation EGFR-targeting drug afatinib has limited efficacy in non-small cell lung cancer patients with EGFR gene exon 20 insertion mutations (ex20ins), and progression-free survival (PFS) It was 2.
New mouse model opens hormone-sensitive human breast cancer drug testing
Time of Update: 2021-11-03
This new mouse model, called NSG-Pro, supports the greatly enhanced growth of implanted er-positive human breast cancer .
Corium Donepezil transdermal patch Adlarity new drug application is expected to be approved next year
Time of Update: 2021-10-21
release of donepezil, the Adlarity transdermal system can regularly deliver the drug through the skin. This design also avoids gastrointestinal absorption and related side effects . Corium
The State Food and Drug Administration issued two guidelines for registration and review of medical device animal testing research
Time of Update: 2021-10-11
>. If the coating composition, morphology and stereological data (thickness, porosity, pore size, etc. ), coating mechanical performance evaluation (coating and substrate bonding strength, etc. ), coating
Luye Pharma's Alzheimer's innovative drug Liss' Mingdo Day transdermal patch is approved for marketing in the UK
Time of Update: 2021-09-30
Guildford, United Kingdom, September 23, 2021/PRNewswire/ - Luye Pharmaceutical Group announced that its self-developed innovative preparation, Liss’ Mindo Day Transdermal Patch, has been
Three drugs selected for the WHO's new crown "Solidarity Test+" project
Time of Update: 2021-08-29
The World Health Organization announced on the 11th that its "Solidarity Test+" project will recruit new crown inpatients to evaluate the efficacy of artesunate, imatinib and infliximab.
WHO will test 3 potential drugs for new crowns
Time of Update: 2021-08-28
WHO will test 3 potential drugs for new crowns>International war "epidemic" operation>Science and Technology Daily, Beijing
WHO launches "Solidarity Test+" to test 3 drugs
Time of Update: 2021-08-26
WHO launches "Solidarity Test+" to test 3 drugs WHO launches "Solidarity Test+" to test 3 drugs WHO launches "Solidarity Test+" to test 3 drugs On August 11, local time, WHO held a routine press conference for new coronary pneumonia.
Early bird discount ends this week, early screening/prognostic testing + drug concomitant/biomarker precision development, the 5th P4 China returns with glory
Time of Update: 2021-08-12
of tumors, from prevention to diagnosis to treatment, from early screening, staging and typing, prognostic testing, companion diagnosis, biomarkers, precision immunization/targeted drug development and transformation, etc. Start a 2-day industry
A seven-year controlled study shows that two Alzheimer's disease test drugs are not as effective as expected
Time of Update: 2021-08-09
" for the prevention of Alzheimer's disease have a significant effect on the The cognitive decline of patients with inherited Alzheimer's disease (DIAD) has no significant effect . >
250,000 people personally test "magic drug" aspirin can reduce the risk of death of cancer patients by 20%
Time of Update: 2021-08-05
Since its launch in 1898, aspirin has been clinically used for more than a hundred years and has become the most widely used antipyretic, analgesic and anti-inflammatory drug in the world .
How should companies that develop "exclusive" companion diagnostic genetic testing for innovative drugs deal with the challenges?
Time of Update: 2021-07-30
During the development of new drugs for precision treatment of patients with biomarker selection, pharmaceutical companies need to communicate with the drug approval center whether they need companion diagnosis before starting key drug clinical trials.